Omeprazol Medreg (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Medreg, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion by inhibiting the H⁺/K⁺‑ATPase enzyme in the stomach lining, and is indicated for the treatment of gastro‑reflux disease, erosive oesophagitis and other acid‑related disorders in adult patients.

GNH USA supplies Omeprazol Medreg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres, clinics and other healthcare institutions worldwide, ensuring consistent quality and regulatory compliance.

Omeprazole is a proton pump inhibitor that reduces gastric acid production, and it is used for several acid‑related gastrointestinal conditions. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Erosive oesophagitis: facilitates mucosal repair and reduces further erosion. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion in this rare endocrine disorder.

Omeprazole may cause a range of adverse reactions, most of which are mild and transient. Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: discomfort in the upper abdomen. - Nausea: occasional feeling of queasiness. Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk with prolonged use. - Anaphylaxis: rare severe allergic reaction requiring immediate medical attention. - Hypomagnesemia: low magnesium levels that may cause muscle cramps or cardiac arrhythmia. - Bone fractures: increased risk with long‑term therapy. - Vitamin B12 deficiency: possible malabsorption with extended treatment. - Elevated liver enzymes: monitor hepatic function if symptoms arise.

Before initiating therapy, consider the following precautions. - Assess renal and hepatic function: adjust therapy if significant impairment is present. - Evaluate for Helicobacter pylori infection: consider eradication therapy before long‑term use. - Monitor electrolytes: prolonged therapy may lead to low magnesium or calcium. - Review concomitant medications: potential interactions may affect efficacy or safety. - Avoid abrupt discontinuation: tapering may reduce rebound acid hypersecretion. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Omeprazole can interact with several medicines; awareness of the interaction level helps manage risk. Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption of atazanavir, compromising HIV therapy. - High‑dose methotrexate: increased toxicity due to reduced renal clearance. Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer anticoagulation monitoring. - Diazepam: increased plasma levels, may enhance sedation. - Digoxin: altered absorption, may necessitate serum level checks.